Indo-MIM IPO Opens July 23: Check Price Band, GMP, Financials, And Key Risks Before You Invest

Indo-MIM IPO Objectives

From the fresh issue proceeds, Indo-MIM plans to use around Rs 400 crore for repaying its loans. The remaining funds, the company will use for general corporate purposes.

Indo-MIM IPO Allotment, Listing Date

The allotment is expected on July 28, while the shares are likely to debut on the NSE and BSE on July 30.

HDFC Bank, Axis Capital, ICICI Securities, Kotak Mahindra Capital Company and SBI Capital Markets are the book-running lead managers to the issue, while MUFG Intime India is the registrar.

What Does Indo-MIM Do

Founded in 1996, Indo-MIM is among the world's largest manufacturers of precision engineering components using metal injection moulding technology. According to the Frost & Sullivan report cited in the red herring prospectus (RHP), the company has the world's largest installed MIM manufacturing capacity. It provides end-to-end solutions ranging from mould design and tooling to finishing and assembly.

The company manufactures products for automotive, defence, medical, aerospace and consumer industries.

Indo-MIM’s Financial Performance

Indo-MIM has reported strong financial growth over the past three financial years. For FY26, the company reported a revenue of Rs 4,320.70 crore, up from Rs 3,373.97 crore in FY25, representing a growth of around 28 per cent. Profit after tax rose to Rs 533.54 crore from Rs 423.73 crore a year ago, an increase of about 26 per cent.

The company also reported an Ebitda of Rs 1,070.92 crore during FY26, while its debt declined to Rs 1,090.49 crore from Rs 1,247.20 crore in the previous year.

Among key profitability metrics, return on equity stood at 21.26 per cent, return on capital employed at 26.60 per cent, and the debt-to-equity ratio improved to 0.39 from 0.57 a year earlier.

Indo-MIM Valuation

At the upper end of the price band of Rs 485, Indo-MIM is seeking a post-issue valuation of around Rs 23,981 crore. The IPO is priced at a post-issue price-to-earnings (P/E) multiple of 44.95 times FY26 earnings, indicating investors will pay nearly 45 times the company's annual earnings for each share. The issue is also valued at a price-to-book (P/B) multiple of 10.63 times, meaning the stock is being offered at over 10 times the company's book value, a measure of its net worth.

Indo-MIM IPO GMP

The grey market premium (GMP) for Indo-MIM IPO remained strong ahead of the issue opening, although it has softened marginally over the past few sessions. Market sources pegged the GMP at Rs 192 on July 22, down from Rs 194 a day earlier and Rs 195 on July 20.

At the current premium, the shares are estimated to list at around Rs 677 apiece, a premium of about 39.6 per cent over the upper end of the issue price of Rs 485, if grey market trends hold until listing.

Indo-MIM IPO: Should You Apply

Here is a SWOT analysis of the Indo-MIM IPO based on disclosures in the company's RHP. Investors should consult their financial advisors and carefully read the prospectus before making any investment decision.

Strengths

Indo-MIM's biggest strength is its scale. According to the Frost & Sullivan Report cited in the RHP, the company has the "world's largest installed MIM capacity". It has also built an integrated manufacturing model, offering "end-to-end solutions including mould design, tooling, finishing, and assembly."

The company has diversified its business across multiple high-value industries, including automotive, defence, medical, aerospace and consumer products. In FY26, it manufactured more than 6,400 products and served over 1,100 customers globally. Indo-MIM has 15 manufacturing facilities in India, the US, the UK and Mexico. It also has sales offices in China, Germany and the US, giving it a strong presence in major global markets.

Financially, the company has delivered consistent growth, with revenue rising 28 per cent and profit after tax increasing 26 per cent in FY26.

Weaknesses

The IPO is largely an exit for existing shareholders. Of the Rs 3,811 crore issue size, only Rs 499 crore is a fresh issue, while Rs 3,311 crore is an offer for sale.

The RHP also shows that a majority of the fresh issue proceeds will not be deployed towards expansion. Instead, the company proposes to use Rs 400 crore for the "repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by our Company", with the balance earmarked for general corporate purposes.

At the upper end of the price band, the IPO is priced at 44.95 times FY26 earnings and values the company at nearly Rs 24,000 crore, leaving investors to assess whether the premium adequately reflects future growth.

Opportunities

The RHP says Indo-MIM has expanded beyond metal injection moulding into "investment casting, precision machining, ceramic injection moulding, and 3D metal printing", allowing it to address a wider range of customer requirements.

Its products are used across sectors with long-term structural growth drivers, including automotive safety systems, medical devices, aerospace and defence. The company also continues to strengthen its international presence through its global manufacturing network and overseas sales operations.

Threats

The RHP highlights that the company serves customers across multiple overseas markets. This makes its business exposed to changes in global demand, customer spending and international economic conditions.

The prospectus also notes that the company operates in precision engineering businesses where maintaining manufacturing quality, technological capabilities and customer relationships is critical. The company could face challenges if it loses major customers or its operations are disrupted.